Device: spy imaging    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
291Hirschsprung disease, entire colon type1

291. Hirschsprung disease, entire colon type    [ 13 clinical trials,   32 drugs,   (DrugBank: 15 drugs),   0 drug target gene,   0 drug target pathway]
Searched query = "Hirschsprung disease, entire colon type", "Hirschsprung disease, small intestine type", "Hirschsprung disease", "Hirschprung disease", "Hirschsprung disease associated entercolitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 13 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04020939
(ClinicalTrials.gov)
March 16, 20202/7/2019The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery.The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery.Intestinal Atresia;Necrotizing Enterocolitis;Hirschsprung Disease;Gastroschisis;Intestinal Obstruction;Incarcerated Hernia;Intussusception;Malrotation;Volvulus;Meconium Ileus;Intestinal Perforation;TraumaDevice: SPY imaging;Drug: Indocyanine GreenSt. Justine's HospitalNULLRecruitingN/A16 YearsAll35N/ACanada